Noradrenergic activity in anticipatory nausea

John H Fetting, M. E. Stefanek, V. R. Sheidler, J. D. Elsworth, S. Piantadosi, R. H. Roth

Research output: Contribution to journalArticle

Abstract

Two studies were conducted to examine the hypothesis that noradrenergic activity is a cause of the anticipatory nausea associated with cancer chemotherapy. In the first study concentrations of plasma 3-methoxy-4- hydroxyphenyl-glycol (MHPG) on day 1 of cycle 5 of initial chemotherapy were significantly higher in patients with than without anticipatory nausea. To determine whether elevated MHPG reflected a clinically significant causative role for noradrenergic activity in anticipatory nausea, we conducted a randomized, double-blind, placebo-controlled, crossover trial of clonidine for anticipatory nausea. At a dose of clonidine that produced significant side effects and reductions of plasma MHPG, anticipatory nausea was improved only marginally. These studies do not support a causative role for noradrenergic activity in anticipatory nausea that can be reduced by clonidine with an acceptable therapeutic index.

Original languageEnglish (US)
Pages (from-to)641-647
Number of pages7
JournalPsychosomatic Medicine
Volume54
Issue number6
StatePublished - 1992

Fingerprint

Nausea
Glycols
Clonidine
Drug Therapy
Cross-Over Studies
Placebos
Neoplasms

Keywords

  • 3-methoxy-4- hydroxyphenyl-glycol (MHPG)
  • anticipatory nausea and vomiting
  • clonidine
  • norepinephrine

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Psychology(all)

Cite this

Fetting, J. H., Stefanek, M. E., Sheidler, V. R., Elsworth, J. D., Piantadosi, S., & Roth, R. H. (1992). Noradrenergic activity in anticipatory nausea. Psychosomatic Medicine, 54(6), 641-647.

Noradrenergic activity in anticipatory nausea. / Fetting, John H; Stefanek, M. E.; Sheidler, V. R.; Elsworth, J. D.; Piantadosi, S.; Roth, R. H.

In: Psychosomatic Medicine, Vol. 54, No. 6, 1992, p. 641-647.

Research output: Contribution to journalArticle

Fetting, JH, Stefanek, ME, Sheidler, VR, Elsworth, JD, Piantadosi, S & Roth, RH 1992, 'Noradrenergic activity in anticipatory nausea', Psychosomatic Medicine, vol. 54, no. 6, pp. 641-647.
Fetting JH, Stefanek ME, Sheidler VR, Elsworth JD, Piantadosi S, Roth RH. Noradrenergic activity in anticipatory nausea. Psychosomatic Medicine. 1992;54(6):641-647.
Fetting, John H ; Stefanek, M. E. ; Sheidler, V. R. ; Elsworth, J. D. ; Piantadosi, S. ; Roth, R. H. / Noradrenergic activity in anticipatory nausea. In: Psychosomatic Medicine. 1992 ; Vol. 54, No. 6. pp. 641-647.
@article{880bb320f0af4b6eaf080451f9099b93,
title = "Noradrenergic activity in anticipatory nausea",
abstract = "Two studies were conducted to examine the hypothesis that noradrenergic activity is a cause of the anticipatory nausea associated with cancer chemotherapy. In the first study concentrations of plasma 3-methoxy-4- hydroxyphenyl-glycol (MHPG) on day 1 of cycle 5 of initial chemotherapy were significantly higher in patients with than without anticipatory nausea. To determine whether elevated MHPG reflected a clinically significant causative role for noradrenergic activity in anticipatory nausea, we conducted a randomized, double-blind, placebo-controlled, crossover trial of clonidine for anticipatory nausea. At a dose of clonidine that produced significant side effects and reductions of plasma MHPG, anticipatory nausea was improved only marginally. These studies do not support a causative role for noradrenergic activity in anticipatory nausea that can be reduced by clonidine with an acceptable therapeutic index.",
keywords = "3-methoxy-4- hydroxyphenyl-glycol (MHPG), anticipatory nausea and vomiting, clonidine, norepinephrine",
author = "Fetting, {John H} and Stefanek, {M. E.} and Sheidler, {V. R.} and Elsworth, {J. D.} and S. Piantadosi and Roth, {R. H.}",
year = "1992",
language = "English (US)",
volume = "54",
pages = "641--647",
journal = "Psychosomatic Medicine",
issn = "0033-3174",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Noradrenergic activity in anticipatory nausea

AU - Fetting, John H

AU - Stefanek, M. E.

AU - Sheidler, V. R.

AU - Elsworth, J. D.

AU - Piantadosi, S.

AU - Roth, R. H.

PY - 1992

Y1 - 1992

N2 - Two studies were conducted to examine the hypothesis that noradrenergic activity is a cause of the anticipatory nausea associated with cancer chemotherapy. In the first study concentrations of plasma 3-methoxy-4- hydroxyphenyl-glycol (MHPG) on day 1 of cycle 5 of initial chemotherapy were significantly higher in patients with than without anticipatory nausea. To determine whether elevated MHPG reflected a clinically significant causative role for noradrenergic activity in anticipatory nausea, we conducted a randomized, double-blind, placebo-controlled, crossover trial of clonidine for anticipatory nausea. At a dose of clonidine that produced significant side effects and reductions of plasma MHPG, anticipatory nausea was improved only marginally. These studies do not support a causative role for noradrenergic activity in anticipatory nausea that can be reduced by clonidine with an acceptable therapeutic index.

AB - Two studies were conducted to examine the hypothesis that noradrenergic activity is a cause of the anticipatory nausea associated with cancer chemotherapy. In the first study concentrations of plasma 3-methoxy-4- hydroxyphenyl-glycol (MHPG) on day 1 of cycle 5 of initial chemotherapy were significantly higher in patients with than without anticipatory nausea. To determine whether elevated MHPG reflected a clinically significant causative role for noradrenergic activity in anticipatory nausea, we conducted a randomized, double-blind, placebo-controlled, crossover trial of clonidine for anticipatory nausea. At a dose of clonidine that produced significant side effects and reductions of plasma MHPG, anticipatory nausea was improved only marginally. These studies do not support a causative role for noradrenergic activity in anticipatory nausea that can be reduced by clonidine with an acceptable therapeutic index.

KW - 3-methoxy-4- hydroxyphenyl-glycol (MHPG)

KW - anticipatory nausea and vomiting

KW - clonidine

KW - norepinephrine

UR - http://www.scopus.com/inward/record.url?scp=0026453670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026453670&partnerID=8YFLogxK

M3 - Article

C2 - 1333617

AN - SCOPUS:0026453670

VL - 54

SP - 641

EP - 647

JO - Psychosomatic Medicine

JF - Psychosomatic Medicine

SN - 0033-3174

IS - 6

ER -